;are useful as inhibitors of mitochondrial F1F0 ATP hydrolase, wherein R1, R5 and R7 are optional substituents, R2, R3 and R4 are hydrogen, alkyl, or substituted alkyl, or comprise a bond to R, T or Y; Z and Y are selected from C(O), CO2, SO2, CH2, CH2C(O), and C(O)C(O), or Z may be absent; R and T are CH2, C(O), or CH(CH2)p(Q), wherein Q is NR10R11, OR10 or CN and p is 0, 1 or 2; R6 is alkyl, alkenyl, substituted alkyl, substituted alkenyl, aryl, cycloalkyl, heterocyclo, or heteroaryl; R10 and R11 are hydrogen, alkyl, or substituted alkyl; and r and t are 0 or 1."/>
公开/公告号US2004009972A1
专利类型
公开/公告日2004-01-15
原文格式PDF
申请/专利号US20030461736
申请日2003-06-13
分类号A61K31/5513;C07D243/14;
国家 US
入库时间 2022-08-21 23:19:23